mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |